NCT00117403

Data

{
  "briefSummary": "The purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ).",
  "completionDate": "2007-09",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "enrollmentCount": 75,
  "enrollmentType": "ESTIMATED",
  "nctId": "NCT00117403",
  "phase": "PHASE1",
  "sponsorId": "national-institute-on-aging-nia",
  "startDate": "2006-01",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Evaluation of the Safety, Tolerability and Impact on Biomarkers of Anti-Oxidant Treatment of Mild to Moderate Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00117403"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version